Target intelligence / Profile preview

Inflammatory activity

Molecular classification
Biological process, Physiological state
01

Overview

Inflammatory activity is a complex biological process characterized by the response of vascular tissues to harmful stimuli, such as pathogens, damaged cells, or irritants (StatPearls, 2023). It involves a coordinated cascade of events including vasodilation, increased vascular permeability, and the recruitment of immune cells like neutrophils and macrophages to the site of injury to initiate defense and repair mechanisms. While acute inflammatory activity is a vital protective response, chronic or dysregulated inflammation serves as a primary driver for a wide array of systemic diseases, including autoimmune disorders, cardiovascular disease, and metabolic syndrome (Nature Medicine, 2019). In the context of drug discovery and clinical pharmacology, 'inflammatory activity' is classified as a physiological state or a therapeutic endpoint rather than a specific molecular target. Pharmacological interventions aim to suppress this activity by targeting specific molecular components of the cascade, such as cytokines, enzymes, or signaling kinases, to restore immune homeostasis (PubMed, 2021). Monitoring this activity through systemic biomarkers like C-reactive protein is essential for assessing disease severity and the efficacy of anti-inflammatory therapies.

Other names
InflammationInflammatory responsePhlogosisSystemic inflammation
02

Mechanism of action

Modulation of the inflammatory cascade through the inhibition of pro-inflammatory cytokines (e.g., TNF-alpha, IL-6), antagonism of specific immune receptors, inhibition of prostaglandin-synthesizing enzymes (COX-1/2), or interference with intracellular signaling pathways such as JAK/STAT and NF-kappaB.

03

Biological functions

Immune responseTissue repairPathogen clearanceHomeostasisVasodilation
04

Disease associations

Rheumatoid arthritisInflammatory bowel diseaseAtherosclerosisAsthmaPsoriasisSepsisType 2 diabetes
05

Safety considerations

Increased susceptibility to opportunistic infectionsImpaired wound healingGastrointestinal ulceration and bleedingAdrenal suppression (associated with chronic corticosteroid use)Potential increased risk of certain malignanciesCardiovascular risks (associated with certain NSAIDs)
06

Interacting drugs

7 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)ProcalcitoninFibrinogen

Beyond the preview

Go deeper on Inflammatory activity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory activity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call